These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2542165)

  • 21. An Epstein-Barr virus-associated superantigen.
    Sutkowski N; Palkama T; Ciurli C; Sekaly RP; Thorley-Lawson DA; Huber BT
    J Exp Med; 1996 Sep; 184(3):971-80. PubMed ID: 9064357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of suppressor T lymphocytes for Epstein-Barr virus-induced B-lymphocyte outgrowth during acute infectious mononucleosis: assessment by two quantitative systems.
    Schooley RT; Haynes BF; Grouse J; Payling-Wright C; Fauci AS; Dolin R
    Blood; 1981 Mar; 57(3):510-7. PubMed ID: 6257313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis.
    Al Tabaa Y; Tuaillon E; Jeziorski E; Ouedraogo DE; Bolloré K; Rubbo PA; Foulongne V; Rodière M; Vendrell JP
    J Clin Virol; 2011 Sep; 52(1):33-7. PubMed ID: 21684200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
    J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukocyte migration inhibition detects cross-reacting antigens between cells transformed by Epstein-Barr virus (EBV) and EBV-like simian viruses.
    Szigeti R; Rabin H; Timar L; Klein G
    Intervirology; 1986; 26(3):121-8. PubMed ID: 3034820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G; Rickinson AB
    Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus.
    Tanaka Y; Sugamura K; Hinuma Y
    J Immunol; 1982 Mar; 128(3):1241-5. PubMed ID: 6173428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms other than polyclonal B cell activation possibly involved in Epstein-Barr virus-induced autoimmunity.
    Garzelli C; Pacciardi A; Basolo F; Falcone G
    Clin Exp Immunol; 1989 Jun; 76(3):412-6. PubMed ID: 2546702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunological cell surface markers in infectious mononucleosis (author's transl)].
    Ritter J; Oehme J
    Klin Wochenschr; 1976 Jul; 54(13):647-8. PubMed ID: 181637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus-transformed B cells can present acetylcholine receptor to autologous autoreactive T cells.
    Hohlfeld R; Michels M; Tesch H; Fahsbender A; Heininger K; Conti-Tronconi BM; Toyka KV
    Immunol Lett; 1986 Mar; 12(2-3):171-4. PubMed ID: 3013761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD8+ T cell subsets of cytotoxic T lymphocytes induced by Epstein-Barr virus infection in infectious mononucleosis.
    Ebihara T; Sakai N; Koyama S
    Tohoku J Exp Med; 1990 Nov; 162(3):213-24. PubMed ID: 1965352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.
    Thorley-Lawson DA
    J Immunol; 1980 Feb; 124(2):745-51. PubMed ID: 6243331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.
    Svedmyr E; Jondal M
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1622-6. PubMed ID: 165518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistological studies of lymphoproliferative lesions in a fatal case of Epstein-Barr virus infection.
    Morgan-Capner P; Morris JA; McIllmurray MB; Thomas JA; Crawford DH; Azim T
    J Clin Pathol; 1986 Dec; 39(12):1317-22. PubMed ID: 3027135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis.
    Svedmyr E; Ernberg I; Seeley J; Weiland O; Masucci G; Tsukuda K; Szigeti R; Masucci MG; Blomogren H; Berthold W
    Clin Immunol Immunopathol; 1984 Mar; 30(3):437-50. PubMed ID: 6199144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
    Koizumi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis.
    Wang F; Blaese RM; Zoon KC; Tosato G
    J Clin Invest; 1987 Jan; 79(1):7-14. PubMed ID: 3025263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody.
    Evans AS; Niederman JC; Cenabre LC; West B; Richards VA
    J Infect Dis; 1975 Nov; 132(5):546-54. PubMed ID: 171321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction.
    Kurth J; Hansmann ML; Rajewsky K; Küppers R
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4730-5. PubMed ID: 12665622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants.
    Moss DJ; Misko IS; Burrows SR; Burman K; McCarthy R; Sculley TB
    Nature; 1988 Feb; 331(6158):719-21. PubMed ID: 2830541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.